A company’s ability to manage the lifecycle of a dossier accurately and efficiently impacts its ability to get to market quickly and maintain the required approvals needed to continue supplying its product.
viabl.ai is the Decision Intelligence platform that embeds AI into the dossier review process, integrating with your data and expertise to accelerate go-to-market for your products.
Operating either on-premise or in the cloud, viabl.ai can extract the information from dossiers and rapidly check the ~700+ data points for omissions and by leveraging an LLM, for correctness.
Tailoring its output to the nuance of each case, viabl.ai can apply variations to checks based on the regional health authority to which the dossier in question is to be submitted. The results of this automated review can then be output to a scientist for final review, or to a manager where required.
Moving forward, viabl.ai also leverages the decision data from each case to create insights into factors that increase the chance of success, allowing businesses to identify regional best-practices and adapt future submissions accordingly.
Results
- Increased likelihood of obtaining HA approval on first submission.
- Reduced likelihood of errors or omissions leading to HA queries and delayed approvals.
- Reduction in cost of dossier review, from five days’ Scientific Review down to approx. 0.5 days, with further cost reductions from lower rework/follow-up effort.
- Easier to access new, previously untapped markets due to the reduced cost of meeting alternative HA requirements/standards.
- Maintained rules and checks with a viabl.ai dashboard for updates whenever local legislation or regulation changes.
.png?width=174&height=60&name=Robiquity-removebg-preview%20(1).png)
